Literature DB >> 26101570

Amino Acid Thioester Derivatives: A Highly Promising Scaffold for the Development of Metallo-β-lactamase L1 Inhibitors.

Xiao-Long Liu1, Ying Shi1, Joon S Kang2, Peter Oelschlaeger3, Ke-Wu Yang1.   

Abstract

In light of the biomedical significance of metallo-β-lactamases (MβLs), ten new mercaptoacetic acid thioester amino acid derivatives were synthesized and characterized. Biological activity assays indicated that all these synthesized compounds are very potent inhibitors of L1, exhibiting an IC50 value range of 0.018-2.9 μM and a K i value range of 0.11-0.95 μM using cefazolin as substrate. Partial thioesters also showed effective inhibitory activities against NDM-1 and ImiS with an IC50 value range of 12-96 and 3.6-65 μM, respectively. Also, all these thioesters increased susceptibility of E. coli cells expressing L1 to cefazolin, indicated by a 2-4-fold reduction in MIC of the antibiotic. Docking studies revealed potential binding modes of the two most potent L1 inhibitors to the active site in which the carboxylate group interacts with both Zn(II) ions and Ser221. This work introduces a highly promising scaffold for the development of metallo-β-lactamase L1 inhibitors.

Entities:  

Keywords:  Antibiotic resistance; L1; inhibitor; mercaptoacetic acid thioester; metallo-β-lactamase; subclass B3

Year:  2015        PMID: 26101570      PMCID: PMC4468392          DOI: 10.1021/acsmedchemlett.5b00098

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  27 in total

1.  Synthesis and SAR of thioester and thiol inhibitors of IMP-1 metallo-beta-lactamase.

Authors:  M L Greenlee; J B Laub; J M Balkovec; M L Hammond; G G Hammond; D L Pompliano; J H Epstein-Toney
Journal:  Bioorg Med Chem Lett       Date:  1999-09-06       Impact factor: 2.823

2.  Overexpression, purification, and characterization of the cloned metallo-beta-lactamase L1 from Stenotrophomonas maltophilia.

Authors:  M W Crowder; T R Walsh; L Banovic; M Pettit; J Spencer
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

3.  Targeted and armed oncolytic adenovirus via chemoselective modification.

Authors:  Partha S Banerjee; Edison S Zuniga; Iwao Ojima; Isaac S Carrico
Journal:  Bioorg Med Chem Lett       Date:  2011-05-20       Impact factor: 2.823

4.  Inhibition of metallo-beta-lactamases by a series of mercaptoacetic acid thiol ester derivatives.

Authors:  D J Payne; J H Bateson; B C Gasson; D Proctor; T Khushi; T H Farmer; D A Tolson; D Bell; P W Skett; A C Marshall; R Reid; L Ghosez; Y Combret; J Marchand-Brynaert
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

5.  Inhibition studies on the metallo-beta-lactamase L1 from Stenotrophomonas maltophilia.

Authors:  K W Yang; M W Crowder
Journal:  Arch Biochem Biophys       Date:  1999-08-01       Impact factor: 4.013

6.  Over-expression, purification, and characterization of metallo-beta-lactamase ImiS from Aeromonas veronii bv. sobria.

Authors:  Patrick A Crawford; Narayan Sharma; Sowmya Chandrasekar; Tara Sigdel; Timothy R Walsh; James Spencer; Michael W Crowder
Journal:  Protein Expr Purif       Date:  2004-08       Impact factor: 1.650

7.  Structural insights into the subclass B3 metallo-β-lactamase SMB-1 and the mode of inhibition by the common metallo-β-lactamase inhibitor mercaptoacetate.

Authors:  Jun-Ichi Wachino; Yoshihiro Yamaguchi; Shigetarou Mori; Hiromasa Kurosaki; Yoshichika Arakawa; Keigo Shibayama
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

8.  Metallo-beta-lactamase inhibitory activity of phthalic acid derivatives.

Authors:  Yukiko Hiraiwa; Akihiro Morinaka; Takayoshi Fukushima; Toshiaki Kudo
Journal:  Bioorg Med Chem Lett       Date:  2009-07-09       Impact factor: 2.823

9.  Antibiotic recognition by binuclear metallo-beta-lactamases revealed by X-ray crystallography.

Authors:  James Spencer; Jonathan Read; Richard B Sessions; Steven Howell; G Michael Blackburn; Steven J Gamblin
Journal:  J Am Chem Soc       Date:  2005-10-19       Impact factor: 15.419

10.  Real-time monitoring of New Delhi metallo-β-lactamase activity in living bacterial cells by 1H NMR spectroscopy.

Authors:  Junhe Ma; Sarah McLeod; Kathleen MacCormack; Shubha Sriram; Ning Gao; Alexander L Breeze; Jun Hu
Journal:  Angew Chem Int Ed Engl       Date:  2014-01-23       Impact factor: 15.336

View more
  10 in total

1.  Structural Insights into Recognition of Hydrolyzed Carbapenems and Inhibitors by Subclass B3 Metallo-β-Lactamase SMB-1.

Authors:  Jun-Ichi Wachino; Yoshihiro Yamaguchi; Shigetarou Mori; Wanchun Jin; Kouji Kimura; Hiromasa Kurosaki; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

2.  Carbamylmethyl Mercaptoacetate Thioether: A Novel Scaffold for the Development of L1 Metallo-β-lactamase Inhibitors.

Authors:  Ya-Nan Chang; Yang Xiang; Yue-Juan Zhang; Wen-Ming Wang; Cheng Chen; Peter Oelschlaeger; Ke-Wu Yang
Journal:  ACS Med Chem Lett       Date:  2017-04-24       Impact factor: 4.345

Review 3.  NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.

Authors:  Wenjing Wu; Yu Feng; Guangmin Tang; Fu Qiao; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

Review 4.  β-lactam/β-lactamase inhibitor combinations: an update.

Authors:  Kamaleddin H M E Tehrani; Nathaniel I Martin
Journal:  Medchemcomm       Date:  2018-08-17       Impact factor: 3.597

5.  Triazolylthioacetamide: A Valid Scaffold for the Development of New Delhi Metallo-β-Lactmase-1 (NDM-1) Inhibitors.

Authors:  Le Zhai; Yi-Lin Zhang; Joon S Kang; Peter Oelschlaeger; Lin Xiao; Sha-Sha Nie; Ke-Wu Yang
Journal:  ACS Med Chem Lett       Date:  2016-02-16       Impact factor: 4.345

6.  Synthesis and mechanistic studies of quinolin-chlorobenzothioate derivatives with proteasome inhibitory activity in pancreatic cancer cell lines.

Authors:  Shuai Hu; Yi Jin; Yanghan Liu; Mats Ljungman; Nouri Neamati
Journal:  Eur J Med Chem       Date:  2018-09-15       Impact factor: 6.514

7.  Virtual Screening and Experimental Testing of B1 Metallo-β-lactamase Inhibitors.

Authors:  Joon S Kang; Antonia L Zhang; Mohammad Faheem; Charles J Zhang; Ni Ai; John D Buynak; William J Welsh; Peter Oelschlaeger
Journal:  J Chem Inf Model       Date:  2018-08-29       Impact factor: 4.956

8.  Mercaptoacetate thioesters and their hydrolysate mercaptoacetic acids jointly inhibit metallo-β-lactamase L1.

Authors:  Cheng Chen; Yang Xiang; Ya Liu; Xiangdong Hu; Ke-Wu Yang
Journal:  Medchemcomm       Date:  2018-05-17       Impact factor: 3.597

Review 9.  Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism.

Authors:  Antonella R Palacios; María-Agustina Rossi; Graciela S Mahler; Alejandro J Vila
Journal:  Biomolecules       Date:  2020-06-03

10.  In vitro and in vivo Inhibitory Activity of NADPH Against the AmpC BER Class C β-Lactamase.

Authors:  Jung-Hyun Na; Tae Hee Lee; Soo-Bong Park; Min-Kyu Kim; Bo-Gyeong Jeong; Kyung Min Chung; Sun-Shin Cha
Journal:  Front Cell Infect Microbiol       Date:  2018-12-21       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.